Dr. Nitish Sharma

Assistant Professor

Tele : 079-66745555

E-mail :

Research Interest

    Extensive characterization of complex injectable products for facilitating generics development, Impurity profiling of drug product, Synthetic peptide characterization, drug-excipient interaction degradation products.


  • April 2021 -Present:
    Assistant Professor, NIPER Ahmedabad, Gujarat, India.
  • June 2013 - April 2021:
    Senior Manager, Analytical Research & Development in Sun Pharmaceutical Industries Limited (India).
  • Feb 2006 - June 2013:
    Scientist, Analytical research- US-Europe market R&D, Dr. Reddys Laboratories Ltd, Hyderabad.


  • A Novel Validated Stability Indicating HPLC Method for Estimation of Degradation behavior of Eberconazole nitrate and Mometasone furoate in cream formulation. (Indian Journal of Pharmaceutical Science 2013; 75(1):76-82).
  • Optimization and Validation of Reverse Phase Liquid Chromatographic Method for Estimation of Cetirizine Mannitol Ester Impurity in Cetirizine Hydrochloride Chewable Tablet. Journal of Liquid Chromatography & Related Technologies.(DOI: 10.1080/10826076.2011.585485)
  • A Novel Validated Ultra High Pressure Liquid Chromatography Method for Separation of Eszopiclone impurities and its degradent in drug product. (Schedule to publish in September-October 2013 issue in journal of AOAC International).
  • A novel and rapid validated stability indicating UPLC method of related substances for Dorzolamide Hydrochloride and Timolol Maleate in Ophthalmic Dosage form. Journal of Chromatographic Science (DOI: 10.1093/chromsci/bms025)
  • A Validated Stability-Indicating Liquid-Chromatographic Method for Ranitidine Hydrochloride in Liquid Oral Dosage Form. Scientia Pharmaceutica [DOI: 10.3797/scipharm.1101-06]
  • A Novel Validated High Pressure Liquid Chromatography Method for Separation of Pioglitazone degradent in drug product. International Journal of Pharmacy and Pharmaceutical Sciences (Volume 4, Supplement 1, 2012).
  • A validated ultra high-pressure liquid chromatography method for separation of Candesartan Cilexetil impurities and its degradents in drug product. Pharmaceutical Methods (DOI: 10.4103-2229-4708.97718).
Go to Navigation